Inhibition of nonhomologous end joining‐mediated DNA repair enhances anti‐HBV CRISPR therapy

Current anti–hepatitis B virus (HBV) therapies have little effect on covalently closed circular DNA (cccDNA) and fail to eliminate HBV. The clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system has been reported to directly target cccDNA and exert antiviral effects. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Murai, Kazuhiro, Kodama, Takahiro, Hikita, Hayato, Shimoda, Akiyoshi, Fukuoka, Makoto, Fukutomi, Keisuke, Shigeno, Satoshi, Shiode, Yuto, Motooka, Daisuke, Higuchi, Yuichiro, Miyakawa, Kei, Suemizu, Hiroshi, Ryo, Akihide, Tahata, Yuki, Makino, Yuki, Yamada, Ryoko, Sakamori, Ryotaro, Tatsumi, Tomohide, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426388/
https://www.ncbi.nlm.nih.gov/pubmed/35608131
http://dx.doi.org/10.1002/hep4.2014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426388/
https://www.ncbi.nlm.nih.gov/pubmed/35608131
http://dx.doi.org/10.1002/hep4.2014

Ejemplares similares